智通财经APP获悉,周二,安进(AMGN.US)股价暴跌,截至发稿,该股跌超10%,报262.37美元。此前该公司表示,其实验性肥胖治疗药物MariTide在使用一年后,可帮助肥胖患者平均减去高达20%的体重,然而这一结果却未能令市场感到满意。华尔街分析师表示,他们预计MariTide在二期试验中至少能减去20%的体重,有些人希望最多能减重25%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.